Business Description
Orthofix Medical Inc
NAICS : 339112
SIC : 3841
ISIN : US68752M1080
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.28 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -1.47 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.31 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1 | |||||
3-Year Book Growth Rate | -4.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.76 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.37 | |||||
9-Day RSI | 51.7 | |||||
14-Day RSI | 49.93 | |||||
6-1 Month Momentum % | 11.93 | |||||
12-1 Month Momentum % | -28.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.54 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 277.14 | |||||
Days Sales Outstanding | 53.84 | |||||
Days Payable | 66.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.1 | |||||
Shareholder Yield % | -14.81 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 65.13 | |||||
Operating Margin % | -16.66 | |||||
Net Margin % | -20.28 | |||||
FCF Margin % | -14.47 | |||||
ROE % | -26.51 | |||||
ROA % | -18.43 | |||||
ROIC % | -18.03 | |||||
ROC (Joel Greenblatt) % | -42.34 | |||||
ROCE % | -20.43 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.64 | |||||
PB Ratio | 0.81 | |||||
Price-to-Tangible-Book | 1.7 | |||||
EV-to-EBIT | -4.1 | |||||
EV-to-EBITDA | -7.22 | |||||
EV-to-Forward-EBITDA | 8.86 | |||||
EV-to-Revenue | 0.77 | |||||
EV-to-Forward-Revenue | 0.72 | |||||
EV-to-FCF | -5.32 | |||||
Price-to-Projected-FCF | 1.06 | |||||
Price-to-Median-PS-Value | 0.38 | |||||
Price-to-Net-Current-Asset-Value | 5.19 | |||||
Earnings Yield (Greenblatt) % | -24.39 | |||||
FCF Yield % | -22 | |||||
Forward Rate of Return (Yacktman) % | 23.16 |